Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful
Jefferies analysts expect a regulatory filing for rocatinlimab later this year, with a product launch in 2026.
Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful Read More »
